Stereospecific analysis of omeprazole in human plasma as a probe for CYP2C19 phenotype

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

S.M. de Morais, G. Wilkinson, Joyce Blaisdell et al. · Journal of Biological Chemistry · 1994 · 952 citations · Full text

Medicine, Genetics, Pharmacology +17

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.

G. Wilkinson, Joyce Blaisdell, Urs Meyer et al. · Molecular Pharmacology · 1994 · 750 citations

Life Sciences, Genetics, Pharmacology +16

Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population*

Takahiro Kubota, Kan Chiba, Takashi Ishizaki · Clinical Pharmacology & Therapeutics · 1996 · 288 citations

Medicine, Genetics, Pharmacology +17

Stereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes

Angela Äbelö, Tommy B. Andersson, Madeleine Antonsson et al. · Drug Metabolism and Disposition · 2000 · 276 citations

Medicine, Pharmacokinetics, Pharmacology +17

genotype–related efficacy of omeprazole for the treatment of infection caused by

Yusuke Tanigawara, N AOYAMA, Tomoko Kita et al. · Clinical Pharmacology & Therapeutics · 1999 · 182 citations

Medicine, Pharmacology, Pharmacotherapy +17